One thing imo the press has not done very well is put the
One thing imo the press has not done very well is put the current epidemic into historical context.
Perhaps the most recent scare with any similarity to covid 19 was the polio epidemic which peaked in the early 50's with an average of 16000 cases /yr in the usa and nearly 2000 deaths /yr in the usa.
So far the usa has had 2 MILLION cases and 113000 deaths (june 11 article) almost all in only the 3.5 months(not one yr) since cases began to become significant.
this has impacted the economy far more than any previous situation in the usa, especially in the last 100 years.
Thus, what is different this time is a crisis of economic and health and fear proportions which is capable of breaking through the usual things which constrain innovation:
1) namely the usual powerful train of inertia which prevents new products from coming to market has been toppled
2)almost all humans live in a tiny box and cannot see anything outside that box- a box more real than physical blinders- we see part of that box in the emphasis on PCR tech
but this cirsis is big enough to force some to think outside the box
Thus, for the 1st time, based on publicly available info,NNLX has more than one suitor. As long as NNLX only had one suitor,big boys no doubt did what they do best- manipulate and control and take advantage of small companies with huge docs written by their armies of lawyers-docs which are hugely manipulative and insulting to the small companies the big boys "bargain" with- but its not typically a bargaining- its typically a very nasty, "take it or leave it,smallfry".
But now due to the above the big boys may be forced to play fair. Now there are multiple suitors - a competition for tech NNLX has.
NNLX is still forced to confront the typical game re its flatpack petri plates but this is a new game.
Also, as one or more have partially pointed out,due to the sheer number of cases and people,there will probably be a mishmash of different testing methods employed until a sufficient number of kits of a clearly superior product can be produced-and even then economics and more traditional games will probably ensure that multiple testing products are still being used,especially for different niches.
This is encouraging for the various testing products,for it greatly reduces the chances that any product will completely become obsolete quickly-reducing the chances of big boys silencing NNLX product (as Mach has pointed out oil co's did re solar etc),especially since big boys likely will be licensing NNLX product.
4
1
Nanologix Inc (NNLX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...
Continue Reading
Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...
Continue Reading
Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...
Continue Reading
The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...
Continue Reading
Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...
Continue Reading
Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...
Continue Reading
In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...
Continue Reading
The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...
Continue Reading
IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...
Continue Reading
A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...
Continue Reading
Top 5 Most Recently Viewed Articles
Teresa Carlile Takes Charge as President of Ridgeland Mortgage Ridgeland Mortgage, a newly established joint venture between loanDepot, Inc. (NYSE: LDI) and Smith Douglas Homes, is excited to announce the appointment of Teresa Carlile as its president. She will be at the helm of operations and strategy, aimed at enhancing the customer finance experience for homebuyers...
Continue Reading
Thumzup Media Corporation Boosts Development Efficiency with AI Thumzup Media Corporation (NASDAQ: TZUP) is making significant strides in software development by integrating state-of-the-art artificial intelligence (AI) technologies into its processes. The company has adopted powerful AI platforms, including GitHub Copilot and Claude AI by Anthropic, enabling its...
Continue Reading
GIBO Unveils Create-to-Earn Module for AI Creators GIBO Holdings Ltd., a prominent player in AI-generated content, is excited to introduce its forthcoming Create-to-Earn module. This innovative feature, currently in beta, aims to act as a vital monetization engine within the GIBO ecosystem. By harnessing the power of AI, this module will enable creators of AI animation...
Continue Reading
Voting Outcomes from Extendicare's Annual Shareholder Meeting MARKHAM, Ontario – Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) has made significant announcements regarding the results of its recent meeting of shareholders. The voting held at the annual meeting highlighted the active participation and engagement of shareholders regarding key...
Continue Reading
Coupang's Impressive Stock Performance Coupang LLC, the leading South Korean e-commerce company, has seen a remarkable jump in its stock price, reaching a notable 52-week high of $24.66. This sharp increase, representing an incredible 44.88% rise over the past year, signals a strong rebound for Coupang. Investors are feeling optimistic about the company’s growth...
Continue Reading